FreeTheAI

Ginkgo Bioworks Expands Cloud Lab Access and Boston Imaging Capability

BullishMedium impact
DNA$13.00 14.64%

Ginkgo Bioworks Holdings, Inc. Class A (NYSE:DNA) expanded its laboratory access and research capabilities through two new operational updates. The biotechnology company granted NSF X-Labs remote access to its Cloud Lab and integrated new advanced imaging equipment at its Nebula Boston facility. Shares of the company rose 14.64% to 13 USD following the announcements.

The arrangement with NSF X-Labs provides researchers with remote cloud lab hours and protein testing capabilities to evaluate synthetic protein designs and AI models. Meanwhile, adding Araceli Biosciences' Endeavor imaging system to Nebula Boston enhances high-content imaging features and enables real-time data collection across active experiments.

Looking ahead, investors will monitor how efficiently these facility upgrades drive experimental throughput and expand remote partner activity. Market participants will watch whether increased cloud testing capacity leads to broader commercial research adoption over time.

Key points

  • Ginkgo Bioworks Holdings, Inc. Class A (NYSE:DNA) granted remote Cloud Lab access to NSF X-Labs for protein testing and AI-model analysis.
  • The company integrated Araceli Biosciences' Endeavor imaging system into its Nebula Boston laboratory facility.
  • The upgraded imaging setup allows real-time, high-content data collection during live biological experiments.
  • Shares of Ginkgo Bioworks Holdings, Inc. Class A (NYSE:DNA) rose 14.64% to trade at 13 USD.

Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org

How we writeDisclaimer

Questions and answers

What remote access did Ginkgo Bioworks grant to NSF X-Labs?

Ginkgo Bioworks granted NSF X-Labs remote access to its Cloud Lab, providing cloud lab time and protein testing resources to express and analyze protein designs, including AI models.

How is Ginkgo Bioworks upgrading its Nebula Boston laboratory?

Ginkgo Bioworks added Araceli Biosciences' Endeavor imaging system to Nebula Boston to expand high-content imaging and enable real-time data collection during experiments.

How did Ginkgo Bioworks stock perform following the news?

Ginkgo Bioworks Holdings, Inc. Class A stock rose 14.64% to 13 USD.